A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Clinical trial NCT02247531 · TERMINATED
Trial details
- NCT number
- NCT02247531
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-06
- Primary completion
- 2018-01-23
- Enrollment
- 975
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.